My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 191

    1.

    Power Shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour.

    Bostom AG, Selhub J, Jacques PF, Rosenberg IH.

    Ann Intern Med. 2001 Jul 17;135(2):133-7.PMID: 11453713 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour.

    Bostom AG, Jacques PF, Liaugaudas G, Rogers G, Rosenberg IH, Selhub J.

    Arterioscler Thromb Vasc Biol. 2002 Mar 1;22(3):488-91.PMID: 11884295 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid.

    Bostom AG, Gohh RY, Liaugaudas G, Beaulieu AJ, Han H, Jacques PF, Dworkin L, Rosenberg IH, Selhub J.

    Atherosclerosis. 1999 Jul;145(1):221-4.PMID: 10428313 [PubMed - indexed for MEDLINE]Related articles

    4.

    Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond.

    Tice JA, Ross E, Coxson PG, Rosenberg I, Weinstein MC, Hunink MG, Goldman PA, Williams L, Goldman L.

    JAMA. 2001 Aug 22-29;286(8):936-43.PMID: 11509058 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour.

    Liaugaudas G, Jacques PF, Selhub J, Rosenberg IH, Bostom AG.

    Arterioscler Thromb Vasc Biol. 2001 May;21(5):849-51.PMID: 11348885 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [Public health control of hyperhomocysteinemia and its consequences]

    Czeizel E, Kalina A.

    Orv Hetil. 2003 Oct 5;144(40):1981-9. Review. Hungarian. PMID: 14626640 [PubMed - indexed for MEDLINE]Related articles

    7.

    Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

    Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M.

    JAMA. 2004 Feb 4;291(5):565-75.PMID: 14762035 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease.

    Malinow MR, Duell PB, Hess DL, Anderson PH, Kruger WD, Phillipson BE, Gluckman RA, Block PC, Upson BM.

    N Engl J Med. 1998 Apr 9;338(15):1009-15.PMID: 9535664 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.

    Clarke R, Armitage J.

    Semin Thromb Hemost. 2000;26(3):341-8. Review.PMID: 11011852 [PubMed - indexed for MEDLINE]Related articles

    10.

    Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.

    Bostom AG, Carpenter MA, Hunsicker L, Jacques PF, Kusek JW, Levey AS, McKenney JL, Mercier RY, Pfeffer MA, Selhub J; FAVORIT Study Investigators.

    Am J Kidney Dis. 2009 Jan;53(1):121-8. Epub 2008 Nov 20.PMID: 19022547 [PubMed - indexed for MEDLINE]Related articles

    11.

    Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.

    B-Vitamin Treatment Trialists' Collaboration.

    Am Heart J. 2006 Feb;151(2):282-7. Review.PMID: 16442889 [PubMed - indexed for MEDLINE]Related articles

    12.

    Lack of association between plasma homocysteine and angiographic coronary artery disease in the era of fortification of cereal grain flour with folic acid.

    Brilakis ES, McConnell JP, Ballman KV, Klee GG, Berger PB.

    Atherosclerosis. 2002 Dec;165(2):375-81.PMID: 12417290 [PubMed - indexed for MEDLINE]Related articles

    13.

    Homocysteine-lowering trials for prevention of heart disease and stroke.

    Clarke R.

    Semin Vasc Med. 2005 May;5(2):215-22. Review.PMID: 16047274 [PubMed - indexed for MEDLINE]Related articles

    14.

    Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain products.

    Robertson J, Iemolo F, Stabler SP, Allen RH, Spence JD.

    CMAJ. 2005 Jun 7;172(12):1569-73.PMID: 15939916 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Sustained homocysteine-lowering effect over time of folic acid-based multivitamin therapy in stroke patients despite increasing folate status in the population.

    Hankey GJ, Eikelboom JW, Loh K, Tang M, Pizzi J, Thom J, Yi Q.

    Cerebrovasc Dis. 2005;19(2):110-6. Epub 2004 Dec 17.PMID: 15608435 [PubMed - indexed for MEDLINE]Related articles

    16.

    The Chilean flour folic acid fortification program reduces serum homocysteine levels and masks vitamin B-12 deficiency in elderly people.

    Hirsch S, de la Maza P, Barrera G, Gattás V, Petermann M, Bunout D.

    J Nutr. 2002 Feb;132(2):289-91.PMID: 11823592 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Clinical trials testing the homocysteine hypothesis.

    Carlsson CM, Stein JH.

    Ann Intern Med. 2002 Aug 20;137(4):295-6. No abstract available. PMID: 12186526 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.

    Gonin JM, Nguyen H, Gonin R, Sarna A, Michels A, Masri-Imad F, Bommareddy G, Chassaing C, Wainer I, Loya A, Cary D, Barker LF, Assefi A, Greenspan R, Mahoney D, Wilcox CS.

    J Nephrol. 2003 Jul-Aug;16(4):522-34.PMID: 14696754 [PubMed - indexed for MEDLINE]Related articles

    19.

    Assessment of three levels of folic acid on serum folate and plasma homocysteine: a randomised placebo-controlled double-blind dietary intervention trial.

    Venn BJ, Mann JI, Williams SM, Riddell LJ, Chisholm A, Harper MJ, Aitken W, Rossaak JI.

    Eur J Clin Nutr. 2002 Aug;56(8):748-54.PMID: 12122551 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.

    Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M; DACH-LIGA Homocystein e.V.

    Clin Chem Lab Med. 2003 Nov;41(11):1392-403. Review. Erratum in: Clin Chem Lab Med. 2004 Jan;42(1):113-6. PMID: 14656016 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity